Task: Answer the multiple-choice question.
Question: What is the human ether-à-go-go related gene (hERG) inhibition at 1uM of a drug with the SMILES CCN1C(=O)C(CC(=O)NCCc2ccccc2)N(NC(=O)c2cccnc2)C1=S?
Constraint: You must return none, one or more options from a, b, c, or d without using any other words.
Options:
a) -12.971
b) 12.874
c) 24.766
d) 0.564
Answer: a. -12.971\%.
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: What is the {herg_central_at_1uM__names__noun} of a {#compound|drug!} with the {SMILES__description} {SMILES#}?
Constraint: You must return none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{herg_central_at_1uM%SMILES%}
Answer: {%multiple_choice_result}. {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCN1C(=O)C(CC(=O)NCCc2ccccc2)N(NC(=O)c2cccnc2)C1=S
CCN1C(=O)C(CC(=O)NCCc2ccccc2)N(NC(=O)c2cccnc2)C1=S
N-[3-ethyl-4-oxo-5-[2-oxo-2-(2-phenylethylamino)ethyl]-2-sulfanylideneimidazolidin-1-yl]pyridine-3-carboxamide